Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
40.64%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $0.30 B
According to Acorda Therapeutics 's latest financial reports the company's total liabilities are $0.30 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Acorda Therapeutics - Total liabilities on balance sheet (from 2003 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.30 B | -0.78% |
| 2021-12-31 | $0.30 B | -22.9% |
| 2020-12-31 | $0.39 B | -19.26% |
| 2019-12-31 | $0.48 B | -28.91% |
| 2018-12-31 | $0.68 B | 1.43% |
| 2017-12-31 | $0.67 B | -0.02% |
| 2016-12-31 | $0.67 B | 33.42% |
| 2015-12-31 | $0.50 B | -3.15% |
| 2014-12-31 | $0.52 B | 214.68% |
| 2013-12-31 | $0.16 B | -7.04% |
| 2012-12-31 | $0.17 B | 2.94% |
| 2011-12-31 | $0.17 B | -8.68% |
| 2010-12-31 | $0.19 B | 4.78% |
| 2009-12-31 | $0.18 B | 145% |
| 2008-12-31 | $74.34 M | 16.39% |
| 2007-12-31 | $63.87 M | -2.78% |
| 2006-12-31 | $65.69 M | -56.33% |
| 2005-12-31 | $0.15 B | 64.33% |
| 2004-12-31 | $91.55 M | 98.64% |
| 2003-12-31 | $46.09 M | |
| 2003-06-30 | $29.47 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $2.40 B | 682.48% | 🇺🇸 USA |
 Repligen
RGEN | $0.85 B | 177.57% | 🇺🇸 USA |
 Affimed
AFMD | $46.53 M | -84.86% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $1.89 B | 514.88% | 🇺🇸 USA |